Spruce biosciences presents phase 1 and 2 data for tildacerfont in adults with congenital adrenal hyperplasia from endocrine society's 2021 annual meeting

San francisco--(business wire)---- $sprb #endo2021--spruce biosciences presents phase 1 and 2 data for tildacerfont in adults with congenital adrenal hyperplasia from endocrine society's 2021 annual mtg

SPRB Ratings Summary

SPRB Quant Ranking